Fractyl Health (GUTS) Debt Ratio (2023 - 2026)
Fractyl Health's (GUTS) quarterly Debt Ratio came in at 0.3 in Q1 2026, down 14.31% YoY from 0.35 in Q1 2025, and up 20.36% on a QoQ basis from 0.25 in Q4 2025.
Fractyl Health (GUTS) Debt Ratio (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Debt Ratio data on file, last reported at 0.3 in Q1 2026.
- Quarterly Debt Ratio fell 14.31% year-over-year to 0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.3 (down 14.31% YoY) and the FY2025 annual result came in at 0.25, down 9.72% from the prior year.
- Debt Ratio rose to 0.3 in Q1 2026, from 0.25 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.48 in Q2 2025 to a low of 0.18 in Q1 2024.
- A 4-year average of 0.29 and a median of 0.27 in 2025 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2024 — Debt Ratio dropped 24.01% — and 2025, when it surged 149.63%.
- Tracing GUTS's Debt Ratio over 4 years: stood at 0.37 in 2023, then retreated by 24.01% to 0.28 in 2024, then dropped by 9.72% to 0.25 in 2025, then grew by 20.36% to 0.3 in 2026.
- The last three Debt Ratio figures came in at 0.3 (Q1 2026), 0.25 (Q4 2025), and 0.27 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 0.47 |
| 10 | Fractyl Health | 125.09 Mn | 125.09 Mn | - | 0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.37 |
| Mar 31, 2026 | 0.30 |
| Dec 31, 2025 | 0.25 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.48 |
| Mar 31, 2025 | 0.35 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | 0.24 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.18 |
| Dec 31, 2023 | 0.37 |